pheochromocytoma
PHEOCHROMOCYTOMA
Pheochromocytoma is a rare adrenal gland tumor that may precipitate life-threatening hypertension.
It can occur at any age but usually occurs during young to mid-adult life.
Majority of patients presents with ≥1 of the following hypertension resistant to standard antihypertensive treatment, hypertensive crisis with malignant hypertension, hypertensive encephalopathy, aortic dissection, or myocardial infarction and paroxysmal symptoms which suggest seizure disorder, anxiety attacks or hyperventilation.

Introduction

  • Pheochromocytomas are catecholamine-secreting tumors arising from chromaffin cells
  • Adrenal medulla is the most common site of origin (approximately 90%)
    • However, tumors may develop anywhere along the abdominal sympathetic chain & are likely to be located near the aorta at the level of the inferior mesenteric artery or at its bifurcation

Etiology

  • Most cases of pheochromocytoma have no known cause
  • In a substantial minority of cases, genetic abnormalities have been identified in some familial forms of pheochromocytoma, as well as those associated with MEN2A and MEN2B, von Hippel-Lindau disease, neurofibromatosis type 1, & paraganglioma syndromes

Signs and Symptoms

  • Pheochromocytoma can occur at any age
    • Usually occurs during young to mid-adult life
  • 10% of patients are asymptomatic

Majority of patients present w/ ≥1 of the following:

  • Hypertension resistant to standard antihypertensive treatment
    • May be associated w/ headaches, excessive sweating &/or palpitations
  • Hypertensive crisis w/ malignant hypertension, hypertensive encephalopathy, aortic dissection or myocardial infarction (MI)
  • Paroxysmal symptoms which suggest seizure disorder, anxiety attacks or hyperventilation
    • Occurs in half of patients
    • Usually sudden in onset but variable in length (eg min-several hr)
    • Associated w/ headache, sweating, palpitations, apprehension, chest or abdomen pain, N/V
    • Pallor may occur
    • Very high BP usually w/ tachycardia

Other Symptoms

  • Increased metabolic rate
    • Mild-moderate wt loss
  • Orthostatic hypotension
    • Results from decreased plasma volume & dulled sympathetic reflexes
  • Cardiac symptoms
    • Sinus tachycardia, sinus bradycardia & other arrhythmias
    • Acute MI or angina may occur even in the absence of coronary artery disease
    • ECG changes
    • Cardiomyopathy
  • Multi-organ system failure w/ noncardiogenic pulmonary edema
  • Carbohydrate intolerance
  • Elevated hematocrit secondary to decreased plasma volume
  • Hypercalcemia
  • Fever, elevated erythrocyte sedimentation rate (ESR)
  • Polyuria, occasionally rhabdomyolysis w/ myoglobinuric renal failure
  • Hypokalemia
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.